428 results on '"Fuller, J. H."'
Search Results
2. Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications study
3. A Student Evaluation of Community Based Education in General Practice
4. The Hypertensive Diabetic Patient
5. Academic Skills Training for Young General Practitioners: the New London Academic Training Scheme (LATS)
6. The Implementation of a Multi-Institution, Multi-Disciplinary Project to Develop Community Undergraduate Medical Education
7. Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study
8. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study
9. Differences in Mortality between African Caribbean and European People with Non-Insulin Dependent Diabetes
10. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials
11. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule
12. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
13. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study
14. Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)
15. Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)
16. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999
17. Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)
18. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study
19. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus
20. Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999
21. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study
22. Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity
23. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
24. Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes
25. Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes
26. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
27. Different risk factors of microangiopathy in patients with Type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study
28. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group
29. Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia
30. ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study
31. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
32. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects
33. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
34. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study
35. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study
36. Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure isn Type 1 diabetes
37. Low-grade inflammation may play an important role in the development of diabetic neuropathy in Type 1 diabetes - the EURODIAB prospective complications study: A87
38. Cardiovascular risk factors predict the development of large fibre dysfunction in diabetic peripheral neuropathy: A49
39. The incidence and risk factors for painful diabetic neuropathy: are females at increased risk?: A48
40. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
41. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case–control study
42. Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study
43. The effect of Atorvastatin therapy on C-reactive protein in patients with Type 2 Diabetes Mellitus and no prior history of cardiovascular disease, in the Collaborative Atorvastatin Diabetes Study (CARDS): A96
44. Risk factors for all-cause mortality in type 1 diabetic patients in Europe, the EURODIAB Prospective Complications Study (PCS): A48
45. Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes
46. Blood pressure and retinopathy help predict the prospective risk of cardiac autonomic neuropathy in Type 1 diabetes mellitus beyond glycaemic control
47. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics
48. Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics
49. Hypertension management in primary prevention Type 2 diabetic patients in the Collaborative Atorvastatin Diabetes Study (CARDS)
50. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factorin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.